A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition to continue immunotherapy treatment for the first time.

These miniature immune system models -- known as human immune organoids -- mimic the real-life environment where immune cells learn to recognize and attack harmful invaders and respond to vaccines.

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of last year’s protection. The coronavirus and influenza are escape artists that ...